Motivation to work with RICHFIELDS

The RICHFIELDS consortium has the opportunity to create a research infrastructure that will be of significant benefit to a wide range of researchers in a number of different disciplines. It could also demonstrate the value of digital technologies to research in other areas. Given my research interests related to ethics and regulation surrounding the use of new technology and the role of the patient/participant, I am very keen to see how the project progresses.

How you have/will contribute to the project

As a member of the project advisory board, and with a background in chemistry, science policy and more recently regulation, governance and ethics, I am hoping to bring a slightly different perspective to the table. My research focuses on the role of participants in medical research, and particularly on the use of digital technologies to support involvement, engagement and participation.

Why the project is of importance

The project is important because of the opportunities it will present to nutrition research, as a result of the data that will be amassed and made available for multidisciplinary researchers, but also for the example it will set to other projects working in different fields. As part of everyday life there is so much data already being gathered that is relevant to population health, an infrastructure that allows this data to be accessed, with the ethical and governance issues taken into consideration, will bring significant benefits to research and to our understanding of health.

Researcher in healthcare and policy

Dr Harriet Teare’s research interests relate to the role of participants in medical research, and improving governance infrastructure to support communication and interactive engagement. She contributes to a number of specific research projects, including providing research governance and ethical support to the DIRECT project – an IMI-JU funded collaboration exploring stratification in Type 2 diabetes, the Rudy project – a research network for rare diseases of the blood, bone and joints, and leads a work package focusing on consent in the Genetics Clinic of the Future – a Horizon 2020 project mapping the complex challenges that will need to be tackled to introduce genome sequencing more widely into the clinic. Harriet obtained a DPhil in Chemistry from Merton College, University of Oxford, and previously worked as a senior policy advisor at Cancer Research UK, focusing on policy issues relating to science and research, and public health.